HBeAg levels predict HBeAg seroconversion during the immune clearance phase of chronic hepatitis B in patients receiving nucleot(s)ide analogue therapy

Julianne Bayliss, Alexander J Thompson, Gillian Rosenberg, Anuj Gaggar, Kathryn M Kitrinos, Mani Subramanian, Patrick Marcellin, Edward J Gane, Henry Lik-Yuen Chan, Xin Li, Danni Colledge, Margaret Littlejohn, Lilly Yuen, Rosalind Edwards, Kathy Jackson, Sara Bonanzinga, Rachel Hammond, Scott Bowden, Stephen Locarnini, Peter A Revill